✦ LIBER ✦

Intra-lesional interleukin-2 for the treatment of in-transit melanoma

✍ Scribed by Kirsty U. Boyd; Bret M. Wehrli; Claire L.F. Temple

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 434 KB
Volume: 104
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21968

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

The use of polyethylene glycol-modified

The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma

✍ James C. Yang; Suzanne L. Topalian; Douglas J. Schwartzentruber; David R. Parkin 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

The hematologic toxicity of interleukin-

The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma

✍ Mark P. Macfarlane; James C. Yang; Anshu S. Guleria; Richard L White Jr.; Claudi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Induction of tyrosinase-reactive T cells

Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha ± interleukin-2 in patients with metastatic melanoma

✍ Alexander Schmittel; Ulrich Keilholz; Regina Max; Eckhard Thiel; Carmen Scheiben 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 2 views

We have shown the presence of tyrosinase-reactive T cells in the peripheral blood of melanoma patients, who had been in remission after treatment with IL-2-containing regimens. In this consecutive study, we analyzed the T-cell response to various peptides derived from tyrosinase in serial blood samp

The use of artificial dermis for surgica

The use of artificial dermis for surgical defects in the treatment of oral premalignant lesions

✍ Chun-Ming Chen; Chia-Fu Yang; Yee-Shyong Shen; I-Yueh Huang; Chih-Fung Wu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Practical guidelines for the management

Practical guidelines for the management of interferon-α-2b side effects in patients receiving adjuvant treatment for melanoma : Expert opinion

✍ Axel Hauschild; Helen Gogas; Ahmad Tarhini; Mark R. Middleton; Alessandro Testor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract Interferon‐α‐2b (IFNα2b) is the only effective adjuvant therapy for melanoma patients at high risk of recurrence that has been approved by regulatory authorities worldwide. However, IFN toxicities increase the risk of poor treatment compliance and impair the potential for benefit from t